ACM
TECH icon

AlphaCrest Capital Management’s Bio-Techne TECH Stock Holding History

AlphaCrest Capital Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-20,248
Closed -$1.44M – 1025
2022
Q3 		$1.44M Buy
20,248
+2,344
+13% +$203K 0.09% 385
2022
Q2 		$1.55M Buy
17,904
+13,048
+269% +$1.22M 0.07% 458
2022
Q1 		$526K Buy
4,856
+3,296
+211% +$340K 0.03% 871
2021
Q4 		$202K Sell
1,560
-1,044
-40% -$128K 0.01% 1335
2021
Q3 		$315K Sell
2,604
-2,664
-51% -$324K 0.02% 1087
2021
Q2 		$593K Buy
+5,268
New +$554K 0.03% 898
2020
Q4 		– Sell
-4,124
Closed -$255K – 1267
2020
Q3 		$255K Sell
4,124
-128
-3% -$8.33K 0.03% 949
2020
Q2 		$281K Sell
4,252
-5,280
-55% -$316K 0.05% 665
2020
Q1 		$452K Buy
9,532
+3,188
+50% +$159K 0.05% 617
2019
Q4 		$348K Buy
6,344
+744
+13% +$39K 0.03% 975
2019
Q3 		$274K Sell
5,600
-16,020
-74% -$803K 0.02% 1123
2019
Q2 		$1.13M Buy
+21,620
New +$1.09M 0.1% 339

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

AlphaCrest Capital Management's TECH Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of Bio-Techne (TECH) in Q4 2022, closing a stake of 20,248 shares — an estimated $1.44M sold.

AlphaCrest Capital Management first reported a position in TECH in Q2 2019 and held it in 12 quarters. The position peaked at $1.55M in Q2 2022. 546 funds tracked by Wall St. Rank hold TECH as of Q4 2022.

  • AlphaCrest Capital Management reported no remaining Bio-Techne position as of Q4 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 20,248 Bio-Techne shares in Q4 2022, an estimated $1.44M.
  • AlphaCrest Capital Management first reported a position in Bio-Techne in Q2 2019 and held it in 12 quarters.
  • AlphaCrest Capital Management's Bio-Techne position peaked at $1.55M in Q2 2022.
  • 546 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.